{"ticker": {"uuid": "f8e31eff-bf58-4238-9e3e-615221cb4575", "symbol": "KLBF", "name": "PT Kalbe Farma Tbk.", "exchange": "JKT", "country": "ID", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "The Hydroxyurea Kalbefarma from PT Kalbe Farma Tbk - steady oral support for chronic myelogenous leu", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaHFQWDNSV1hHM0hSU1lNMVpDckJuaHM2MXc1U1ZvZ0V5bFAzMDJON0hJU2J2Vmh3b0hyb2szZEQ4YVVPUVROWHVUc0lTLTc4NEt0cTlXZ081VDVWNnF1dTBTNWIzLTdUMWNQU1VQV0pZMnpIUXNZYjNQNTF3S1R0QnhwQWlHT1ZuaDJLZjhaYmhqV0VQWWc1RG5adkpTTVJrckhFdVhNVkZ4WTA5QllsMFJzNW5TUTQ1TG00SDN2THRKeDBpcW5NNQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-28T02:38:52+00:00", "published_display": "28 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma builds on healthcare portfolio, shares tracked against regional pharma peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxONnF5MzQzcU1OOG9jdFNKMFJBUGdUSURFMm5lX0s2N245VUtaSm4yZFFndTZGNjlUc2NJWUJMLU0ycjcwX3B2djFZS2tVUmEtcVpJczBCRmdOVXRjR29GX0o5M29BbzlnN1FSSEFFWWJ5MlJJS01ycnd0V0U0LTZtRVZfdFNrQTVuOExnVUpUbXZKVGcwNWU3c0NUUjJKS3VENUJ6S1JDcHZNTUV4eXR0aTk3QU5XQVhiYXNqbDVWNlZUdw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-26T21:01:03+00:00", "published_display": "26 Jun 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PT Kalbe Farma Tbk \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQaTlRODdheDFDRUVZbVBMbzZKUi12X2IyNi0xMGZJaDQxR2hWVkhfbFhucFZVZzJELWRFLVd0N1lac2dtSk40bjhBRjlFNmNGeFJLVlhvYVlIUjRQckJPRHRpTS1wSzZhcjZOWUo5T0h5V09Ua0ZTdmhZU3dyLUR4UmtqWGdHNnFjWXdqaXFLOGRtMkdiSlFCOHk2bUJ5QQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T05:05:29+00:00", "published_display": "26 Jun 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma profit rises 10.63%, shares react positively", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYk5NSWFKMjJPejRaZ0ZXams5Z2duaGs5ZmZEUm1vYkVPZGUxbTNzaW1PY1hGaDNNUGFsQVh0QktDQTlpcVRLWkg1N1QtSjExUGxYa1ptNTRmU293cnlKM0hQRUhJbC1CUUJlai1TV1IzYU9oQjduRVRfV2laelZ3UnFBV0dnMXMtaFFtdGN1ZW9Ka3BUZjZhWDdINA?oc=5", "source_name": "IDNFinancials.com", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Continues Collaboration with Monash University, Indonesia, Enhancing Management Expertise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPS3FHQjNYc3dreGFJM3FuLVRDN1RxblprV1hkUUpoNDd5bF9jYThuX3BtcTlWVENtU2R2ZjdMRlcwVVBHSEdIbkJQNGhpb3RhRG94ZmxaOEwtWlpoN2JDOVMwLVpVNGZXVUxlZk9OYzdYMXMzU0RDdDNab3VidjBtMXVNaHZhV3Z5SXBLQTBHWGhIcGtjR3ZYM0U1NUVNdlF5SEhuWXhucFIycGtuZnIzSEdNWWFVLXZpSkROOUpMVlR6MVEzTW10Uk4yYw?oc=5", "source_name": "Monash University", "published_at": "2024-04-24T07:00:00+00:00", "published_display": "24 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PT Kalbe Farma Tbk Earnings and Revenue \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1qeGx0dzAtc0FrUW9KVUZjTExOQXltelJ2Tk1rWTZhRzA2TVIwOXY3M25VbnJIVzJoanN1S2pRZkNQYTZnSjFTSmhDN3ExSXRJSFpwTHdpdUJONlUzdnp4MzlrSkU4dzFrSGdvdlRiRGZ0OXM?oc=5", "source_name": "TradingView", "published_at": "2024-04-13T18:26:46+00:00", "published_display": "13 Apr 2024 18:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PT Kalbe Farma Tbk Dividends \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5Yc1RLcEJVWjVoQTlQUEFOYWMyTFktWTI4aWVHNG5QQkdiYjZZNWxlYnBzVVhaWDBSYy1pUFFZVFg3cGZucmVqN2J1dU9MOXUwNGNpcFZDckU5eG5nanFkUnRyNUpPVE5iVldyLVlrdHFxNzRq?oc=5", "source_name": "TradingView", "published_at": "2023-09-01T11:06:06+00:00", "published_display": "01 Sep 2023 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma, A Pharmaceutical Company Owned By The Conglomerate Boenjamin Setiawan, Generated Sales Of IDR 6.01 Trillion In The First Quarter Of 2021", "summary": "", "url": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFB4cWN3SkdDQ1hHdVdtbzRZWVEybENWYmdwbkVWaGNjZHA5WHZlSjhKajJ3dTBGNWNsLVV2Mkx3bEs1a19sRFHSAUBBVV95cUxPNDVGdWJfR0lQYnE1TDFqSGU0akhNNi1rN0FiLTZaRTZfZklJSTVDamFNZF83N1FONkVjeTJhUEN1?oc=5", "source_name": "VOI.ID", "published_at": "2022-12-24T06:49:41+00:00", "published_display": "24 Dec 2022 06:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Indonesia\u2019s Kalbe Farma weighs food unit IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNODdVNzN1bzc1bXRPVkpoN3o0UnNYNkpoQTNPdUxlOFI2TktiS2NXVGJqVzR3U090N0lVVGFyMFVzSFJnV09HWlFNa3hVVjRlTWphMUNGa2szdU9fUXN0LUVZdzZ2M0FIVHc1SnZnT2tzX01CV0hVTFFvcmhRMEduNE1heFk0MmhxTjRqaWY0Zlo?oc=5", "source_name": "The Malaysian Reserve", "published_at": "2020-08-25T07:00:00+00:00", "published_display": "25 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of PT Kalbe Farma Tbk (IDX:KLBF)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1KbU1oM1h5dzZMcHB3ZHhsWU1STTlkdUppZnJkZFdmalM0ZEQwdzN4WWZlbFZCOWlHejBQN2JaMGszdWpWZ0FMVS1aTFBQYjk1Z2pDX1RtbGM1bFpnZ00wY0NIOTlGdWs?oc=5", "source_name": "TradingView", "published_at": "2018-03-07T18:33:25+00:00", "published_display": "07 Mar 2018 18:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "The Hydroxyurea Kalbefarma from PT Kalbe Farma Tbk - steady oral support for chronic myelogenous leu", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaHFQWDNSV1hHM0hSU1lNMVpDckJuaHM2MXc1U1ZvZ0V5bFAzMDJON0hJU2J2Vmh3b0hyb2szZEQ4YVVPUVROWHVUc0lTLTc4NEt0cTlXZ081VDVWNnF1dTBTNWIzLTdUMWNQU1VQV0pZMnpIUXNZYjNQNTF3S1R0QnhwQWlHT1ZuaDJLZjhaYmhqV0VQWWc1RG5adkpTTVJrckhFdVhNVkZ4WTA5QllsMFJzNW5TUTQ1TG00SDN2THRKeDBpcW5NNQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-28T02:38:52+00:00", "published_display": "28 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma builds on healthcare portfolio, shares tracked against regional pharma peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxONnF5MzQzcU1OOG9jdFNKMFJBUGdUSURFMm5lX0s2N245VUtaSm4yZFFndTZGNjlUc2NJWUJMLU0ycjcwX3B2djFZS2tVUmEtcVpJczBCRmdOVXRjR29GX0o5M29BbzlnN1FSSEFFWWJ5MlJJS01ycnd0V0U0LTZtRVZfdFNrQTVuOExnVUpUbXZKVGcwNWU3c0NUUjJKS3VENUJ6S1JDcHZNTUV4eXR0aTk3QU5XQVhiYXNqbDVWNlZUdw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-26T21:01:03+00:00", "published_display": "26 Jun 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PT Kalbe Farma Tbk \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQaTlRODdheDFDRUVZbVBMbzZKUi12X2IyNi0xMGZJaDQxR2hWVkhfbFhucFZVZzJELWRFLVd0N1lac2dtSk40bjhBRjlFNmNGeFJLVlhvYVlIUjRQckJPRHRpTS1wSzZhcjZOWUo5T0h5V09Ua0ZTdmhZU3dyLUR4UmtqWGdHNnFjWXdqaXFLOGRtMkdiSlFCOHk2bUJ5QQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T05:05:29+00:00", "published_display": "26 Jun 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma profit rises 10.63%, shares react positively", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYk5NSWFKMjJPejRaZ0ZXams5Z2duaGs5ZmZEUm1vYkVPZGUxbTNzaW1PY1hGaDNNUGFsQVh0QktDQTlpcVRLWkg1N1QtSjExUGxYa1ptNTRmU293cnlKM0hQRUhJbC1CUUJlai1TV1IzYU9oQjduRVRfV2laelZ3UnFBV0dnMXMtaFFtdGN1ZW9Ka3BUZjZhWDdINA?oc=5", "source_name": "IDNFinancials.com", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Continues Collaboration with Monash University, Indonesia, Enhancing Management Expertise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPS3FHQjNYc3dreGFJM3FuLVRDN1RxblprV1hkUUpoNDd5bF9jYThuX3BtcTlWVENtU2R2ZjdMRlcwVVBHSEdIbkJQNGhpb3RhRG94ZmxaOEwtWlpoN2JDOVMwLVpVNGZXVUxlZk9OYzdYMXMzU0RDdDNab3VidjBtMXVNaHZhV3Z5SXBLQTBHWGhIcGtjR3ZYM0U1NUVNdlF5SEhuWXhucFIycGtuZnIzSEdNWWFVLXZpSkROOUpMVlR6MVEzTW10Uk4yYw?oc=5", "source_name": "Monash University", "published_at": "2024-04-24T07:00:00+00:00", "published_display": "24 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PT Kalbe Farma Tbk Earnings and Revenue \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1qeGx0dzAtc0FrUW9KVUZjTExOQXltelJ2Tk1rWTZhRzA2TVIwOXY3M25VbnJIVzJoanN1S2pRZkNQYTZnSjFTSmhDN3ExSXRJSFpwTHdpdUJONlUzdnp4MzlrSkU4dzFrSGdvdlRiRGZ0OXM?oc=5", "source_name": "TradingView", "published_at": "2024-04-13T18:26:46+00:00", "published_display": "13 Apr 2024 18:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PT Kalbe Farma Tbk Dividends \u2013 IDX:KLBF", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5Yc1RLcEJVWjVoQTlQUEFOYWMyTFktWTI4aWVHNG5QQkdiYjZZNWxlYnBzVVhaWDBSYy1pUFFZVFg3cGZucmVqN2J1dU9MOXUwNGNpcFZDckU5eG5nanFkUnRyNUpPVE5iVldyLVlrdHFxNzRq?oc=5", "source_name": "TradingView", "published_at": "2023-09-01T11:06:06+00:00", "published_display": "01 Sep 2023 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalbe Farma, A Pharmaceutical Company Owned By The Conglomerate Boenjamin Setiawan, Generated Sales Of IDR 6.01 Trillion In The First Quarter Of 2021", "summary": "", "url": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFB4cWN3SkdDQ1hHdVdtbzRZWVEybENWYmdwbkVWaGNjZHA5WHZlSjhKajJ3dTBGNWNsLVV2Mkx3bEs1a19sRFHSAUBBVV95cUxPNDVGdWJfR0lQYnE1TDFqSGU0akhNNi1rN0FiLTZaRTZfZklJSTVDamFNZF83N1FONkVjeTJhUEN1?oc=5", "source_name": "VOI.ID", "published_at": "2022-12-24T06:49:41+00:00", "published_display": "24 Dec 2022 06:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Indonesia\u2019s Kalbe Farma weighs food unit IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNODdVNzN1bzc1bXRPVkpoN3o0UnNYNkpoQTNPdUxlOFI2TktiS2NXVGJqVzR3U090N0lVVGFyMFVzSFJnV09HWlFNa3hVVjRlTWphMUNGa2szdU9fUXN0LUVZdzZ2M0FIVHc1SnZnT2tzX01CV0hVTFFvcmhRMEduNE1heFk0MmhxTjRqaWY0Zlo?oc=5", "source_name": "The Malaysian Reserve", "published_at": "2020-08-25T07:00:00+00:00", "published_display": "25 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of PT Kalbe Farma Tbk (IDX:KLBF)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1KbU1oM1h5dzZMcHB3ZHhsWU1STTlkdUppZnJkZFdmalM0ZEQwdzN4WWZlbFZCOWlHejBQN2JaMGszdWpWZ0FMVS1aTFBQYjk1Z2pDX1RtbGM1bFpnZ00wY0NIOTlGdWs?oc=5", "source_name": "TradingView", "published_at": "2018-03-07T18:33:25+00:00", "published_display": "07 Mar 2018 18:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 65, "total_relevant": 10, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 9, "score": 52, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 725.0, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": -2.0, "twelve_week_move": -22.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.565716, "market_dynamics_buy_signal": false, "relative_strength": -13.366748, "fair_value_gap": -46.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.0012, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, -2.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 4}, {"label": "ad-hoc-news.de", "count": 2}, {"label": "IDNFinancials.com", "count": 1}, {"label": "Monash University", "count": 1}, {"label": "VOI.ID", "count": 1}, {"label": "The Malaysian Reserve", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Earnings", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.3% over one week, -2.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "The Hydroxyurea Kalbefarma from PT Kalbe Farma Tbk - steady oral support for chronic myelogenous leu"}], "updated_at": "2026-07-18T07:06:26.378115+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}